GO FUND IT NOW

BRIGHAM AND WOMEN'S HOSPITAL

The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection

The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection is a funding opportunity from BRIGHAM AND WOMEN'S HOSPITAL, up to 662076, closing June 30, 2028.

Funder
BRIGHAM AND WOMEN'S HOSPITAL
Funding
662076
Deadline
Jun 30, 2028
(700d left)

Overview

Antibody-mediated rejection (AMR) in kidney transplantation remains a major cause of kidney graft loss and a critical hurdle to improve long term allograft survival, with no approved therapy. Antibody responses are tightly controlled through T follicular helper (Tfh) cells. Understanding the role of Tfh in kidney…

The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection | Go Fund It Now